IFNA1 and neoplasm: OVs improve immune system recognition of tumor cells by upregulating pathways that are involved in antigen processing and presentation, including increasing MHC class I/II expression on APCs and tumor cells, promoting tumor-associated antigen presentation and recognition, stimulating potential class I IFN responses, and stimulating chemokine production, thereby recruiting T cells and promoting anti-tumor T-cell responses (84).